Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Mobia Medical, Inc. (MOBI)

Mobia Medical Q2 revenue rises 102% to $13.5 million; net loss widens to $21.0 million

Mixed Impact 3 of 5 earnings Written later

Mobia Medical reported second-quarter 2026 revenue of $13.5 million, up 102% from a year earlier, and gave full-year 2026 revenue guidance of $54.0 million to $56.0 million. Operating expenses rose 83% to $29.2 million, and the net loss widened to $21.0 million from $10.5 million, so revenue growth came with a larger loss for shareholders.

Key points

  • Q2 2026 revenue $13.5 million vs. $6.7 million in Q2 2025; gross margin 83.2% vs. 82.3%
  • Net loss $21.0 million vs. $10.5 million a year earlier; loss per share $1.10 vs. $12.44, reflecting more weighted-average shares after the IPO
  • Full-year 2026 revenue outlook $54.0 million to $56.0 million, growth of 69% to 75%
  • Cash and cash equivalents $177.1 million at June 30, 2026, including about $134.0 million net IPO proceeds

The filing

CompanyMobia Medical, Inc. (MOBI)
Form8-K, current report
Filed with the SECAug 11, 2026, 4:12 PM ET
Accession number0001193125-26-344666

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.